Cargando…

Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes

BACKGROUND: Reverse phase protein array (RPPA) analysis, allows investigation of potential targets at the functional protein level,. We identified TNBC subtypes at the protein level using RPPA and compared them with mRNA molecular subtypes (TNBCtype, TNBCtype-4, and PAM50) that is unique in its avai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masuda, Hiroko, Qi, Yuan, Liu, Shuying, Hayashi, Naoki, Kogawa, Takahiro, Hortobagyi, Gabriel N., Tripathy, Debu, Ueno, Naoto T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642571/ https://www.ncbi.nlm.nih.gov/pubmed/29050296 http://dx.doi.org/10.18632/oncotarget.19719

Ejemplares similares

Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers
por: Masuda, Hiroko, et al.
Publicado: (2013)

Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype
por: Funakoshi, Yohei, et al.
Publicado: (2019)

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
por: Harano, Kenichi, et al.
Publicado: (2018)

Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?
por: Le Du, Fanny, et al.
Publicado: (2015)

cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer
por: Sohn, Joohyuk, et al.
Publicado: (2014)

Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer
por: Xie, Xuemei, et al.
Publicado: (2023)

EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer
por: Wang, Xiaoping, et al.
Publicado: (2017)

Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines
por: Xie, Xuemei, et al.
Publicado: (2023)

Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy
por: Masuda, Hiroko, et al.
Publicado: (2022)

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
por: Chen, Xi, et al.
Publicado: (2012)

Subtyping Of Triple Negative Breast Carcinoma On The Basis Of RTK Expression
por: Hessel, Harald, et al.
Publicado: (2018)

Triple-negative breast cancer molecular subtyping and treatment progress
por: Yin, Li, et al.
Publicado: (2020)

Molecular stratification within triple-negative breast cancer subtypes
por: Wang, Dong-Yu, et al.
Publicado: (2019)

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping
por: Yu, Xinjian, et al.
Publicado: (2022)

Triple Negative Breast Cancer: An Analysis of the Subtypes and the Effects of Menopausal Status on Invasive Breast Cancer
por: Nishimura, Reiki, et al.
Publicado: (2022)

Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2020)

Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer
por: Gagliardi, Maria, et al.
Publicado: (2020)

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
por: Liu, Yi-Rong, et al.
Publicado: (2016)

Optical Redox Imaging Differentiates Triple-Negative Breast Cancer Subtypes
por: Jiang, Jinxia, et al.
Publicado: (2021)

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
por: Cserni, Gábor, et al.
Publicado: (2021)

Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer
por: Wang, Maoli, et al.
Publicado: (2022)

Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes
por: Araujo, Jhajaira M., et al.
Publicado: (2022)

Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity
por: Ding, Yuan Chun, et al.
Publicado: (2019)

Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
por: Giuli, M. V., et al.
Publicado: (2019)

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
por: Jézéquel, Pascal, et al.
Publicado: (2019)

Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
por: Hill, David P., et al.
Publicado: (2019)

Radiomics in Triple Negative Breast Cancer: New Horizons in an Aggressive Subtype of the Disease
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications
por: Asleh, Karama, et al.
Publicado: (2022)

Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer
por: Pu, Shengyu, et al.
Publicado: (2022)

Rare subtypes of triple negative breast cancer: Current understanding and future directions
por: Thomas, Alexandra, et al.
Publicado: (2023)

Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer
por: Tong, Ling, et al.
Publicado: (2023)

Family history of breast and ovarian cancer and triple negative subtype in hispanic/latina women
por: Anderson, Kristin, et al.
Publicado: (2014)

Potential therapeutic targets of triple-negative breast cancer based on its intrinsic subtype
por: Shao, Fangyuan, et al.
Publicado: (2017)

The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer
por: Liao, Hong-Ye, et al.
Publicado: (2018)

Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy
por: Santonja, Angela, et al.
Publicado: (2018)

Integrative Analysis Reveals Subtype-Specific Regulatory Determinants in Triple Negative Breast Cancer
por: Huang, Shujun, et al.
Publicado: (2019)

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
por: Lehmann, Brian D., et al.
Publicado: (2016)

Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma
por: González-Martínez, Silvia, et al.
Publicado: (2020)

A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype
por: Chen, Zihao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kjf9218c5s735e93t1tgeris5h